Malnutrition Within Heart Failure Phenotypes

> Research explainer: This briefing examines verified primary research published 74 days before the briefing date. It is not a same-day research update and does not provide medical advice.

This research explainer examines a retrospective clustering study of 407 people hospitalized with heart failure who had atrial fibrillation on admission. The investigators used demographic, laboratory, and discharge-treatment variables to identify four clinical phenotypes. [pmid:42328189]

Evidence

The study drew its data from the single-center Acute Heart Failure Registry in the Osaka Rosai Hospital and included patients admitted for acute decompensated heart failure between January 2015 and December 2022 who showed atrial fibrillation on admission. [pmid:42328189] The clustering inputs were age, sex, NT-proBNP, creatinine, hemoglobin, albumin, and use of several heart-failure medication categories at discharge. [pmid:42328189]

Four phenotypes with distinct clinical profiles were identified. [pmid:42328189] Phenotype 1 consisted of younger, predominantly male patients with relatively reduced left-ventricular ejection fraction, a comparatively preserved systemic condition, and the greatest use of guideline-directed medical therapy; it had the most favorable outcomes. [pmid:42328189] Phenotype 2 had intermediate frailty and moderate guideline-directed medical therapy use. [pmid:42328189] Phenotype 3 was characterized by advanced age, systemic impairment, renal dysfunction, and anemia. [pmid:42328189]

Phenotype 4 was described as the oldest and most frail group, characterized by severe malnutrition and minimal guideline-directed medical therapy. [pmid:42328189] Nutrition-related status entered the clustering framework through albumin, while the reported phenotype description referred to severe malnutrition. [pmid:42328189] This means the nutrition signal was evaluated alongside age, cardiac biomarker status, kidney function, anemia, sex, and discharge medication patterns rather than as an isolated exposure. [pmid:42328189]

The primary endpoint was a composite of all-cause death and heart-failure readmission. [pmid:42328189] Over a median follow-up of 612 days, outcomes worsened progressively across the four phenotypes. [pmid:42328189] Relative to Phenotype 1, the reported hazard ratios for the composite endpoint were 1.87, 3.80, and 4.60 across the progressively higher-risk phenotypes, with a trend p value below 0.001. [pmid:42328189] Kaplan-Meier curves also showed significant separation in event-free survival among groups. [pmid:42328189]

Analysis — Nutrition as a profile marker

The central digestion-and-nutrition relevance is not that the study tested a dietary strategy. Instead, it identified severe malnutrition as one feature of the phenotype with the greatest observed composite risk. [pmid:42328189] That framing matters: the high-risk group also had the greatest age and frailty and minimal guideline-directed medical therapy, while the clustering procedure incorporated renal function, anemia, cardiac biomarker status, and other variables. [pmid:42328189] The study therefore supports viewing malnutrition here as part of a broad clinical profile associated with poorer observed outcomes, rather than as a stand-alone explanation for those outcomes. [pmid:42328189]

Albumin was among the selected laboratory parameters because it reflected nutritional status in the clustering analysis. [pmid:42328189] Yet an albumin-informed cluster is not equivalent to a demonstration that a specific digestive disorder, food intake pattern, absorption problem, or nutritional deficiency drove prognosis. [pmid:42328189] The available evidence does not separate the contribution of malnutrition from correlated features such as frailty, renal dysfunction, anemia, illness severity, or treatment tolerability. [pmid:42328189]

The treatment pattern also requires restraint in interpretation. Discharge medications were deliberately included because prescription patterns may reflect therapeutic strategies and clinical conditions including frailty, hemodynamic status, renal dysfunction, blood pressure, comorbidity burden, and treatment tolerability. [pmid:42328189] Consequently, minimal guideline-directed medical therapy in Phenotype 4 should not be read as evidence that nutrition status determined treatment use, nor as proof that a nutritional change would alter the endpoint. [pmid:42328189] The study’s useful contribution is descriptive prognostic stratification within this hospitalized heart-failure-and-atrial-fibrillation population. [pmid:42328189]

Limitations

This was a retrospective observational analysis at one center, so it can identify associations and phenotype patterns but cannot establish causation. [pmid:42328189] The population was limited to people hospitalized with acute decompensated heart failure who had atrial fibrillation on admission, which limits how directly the findings can be applied beyond that setting. [pmid:42328189] Malnutrition was embedded in a multidimensional phenotype rather than tested independently. [pmid:42328189] The supplied evidence provides no standalone prevalence estimate for malnutrition and no detailed nutritional measures beyond the albumin-based clustering context. [pmid:42328189] It also reports no nutritional intervention, so it does not show whether improving nutrition changes death, readmission, medication use, or any other outcome. [pmid:42328189]